# Centivax

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/centivax

- Industry: Biotechnology
- Headquarters: South San Francisco, US
- Website: www.centivax.com
- Total disclosed funding: $55M
- Latest round: Series A (Jul 8, 2025)
- Investors on record: 7

## About

Founded in 2020 and based in California, US, Centivax, Inc. operates as a biotechnology company that focuses on the research and development of vaccines. In March 2026, Centivax, Inc. raised USD 37 million in venture funding led by Structure Fund, with participation from Meiji Seika Pharma, Sigmas Group, Kendall Capital Partners, and individual investors. Centivax's portfolio includes broad-spectrum vaccines to treat infectious diseases like the flu and COVID, broad-spectrum anti-infectives, and broad-spectrum snake anti-venom. The portfolio first targets the three rapidly mutating pathogens responsible for the most infections and deaths in humans: seasonal and pandemic influenza viruses(flu), coronaviruses (COVID-19), and HIV(AIDS). Additionally, Centivax’s platform is designed to teach the immune system to target critical regions of viral spike proteins that the viruses are not able to mutate. The technology platform is compatible with, and IP covers, major vaccine delivery technologies including well-established recombinant protein-based vaccines, VLPs, and recent mRNA platforms. The company will use the March 2026 funding to progress its flu vaccine to a Phase 2 trial in early 2027 and extend runway into 2028.

## Funding rounds

- Series A, Jul 8, 2025, $45M — Amplify Partners, BOLD Capital Partners, NFX, Future Ventures, Kendall Capital Partners, Base4 Capital
- Seed, Nov 16, 2022, $10M — NFX, Global Health Investment Advisors

## Investors

- NFX (https://capitalatlas.ai/funds/nfx) — Seed, Series A
- Global Health Investment Advisors — Seed
- Amplify Partners (https://capitalatlas.ai/funds/amplify-partners) — Series A
- BOLD Capital Partners (https://capitalatlas.ai/funds/bold-capital-partners) — Series A
- Future Ventures — Series A
- Kendall Capital Partners (https://capitalatlas.ai/funds/kendall-capital-partners) — Series A
- Base4 Capital (https://capitalatlas.ai/funds/base4-capital) — Series A